Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+Tregs to restrict murine tumor growth
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+Tregs to restrict murine tumor growth
Authors
Keywords
-
Journal
Immunotherapy
Volume 3, Issue 8, Pages 949-969
Publisher
Future Medicine Ltd
Online
2011-08-16
DOI
10.2217/imt.11.81
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neem Leaf Glycoprotein Partially Rectifies Suppressed Dendritic Cell Functions and Associated T Cell Efficacy in Patients with Stage IIIB Cervical Cancer
- (2011) Soumyabrata Roy et al. Clinical and Vaccine Immunology
- Host APCs Augment In Vivo Expansion of Donor Natural Regulatory T Cells via B7H1/B7.1 in Allogeneic Recipients
- (2011) T. Yi et al. JOURNAL OF IMMUNOLOGY
- 4-1BB Ligand as an Effective Multifunctional Immunomodulator and Antigen Delivery Vehicle for the Development of Therapeutic Cancer Vaccines
- (2010) R. K. Sharma et al. CANCER RESEARCH
- Restoration of dysregulated CC chemokine signaling for monocyte/macrophage chemotaxis in head and neck squamous cell carcinoma patients by neem leaf glycoprotein maximizes tumor cell cytotoxicity
- (2010) Krishnendu Chakraborty et al. Cellular & Molecular Immunology
- Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells
- (2010) Sameena Khan et al. CLINICAL IMMUNOLOGY
- Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of anti-tumor immunity by allowing generation of immune effector/memory response
- (2010) Koustav Sarkar et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- OX40 costimulation can abrogate Foxp3+regulatory T cell-mediated suppression of antitumor immunity
- (2009) Naomi Kitamura et al. INTERNATIONAL JOURNAL OF CANCER
- Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions
- (2009) Shyamal Goswami et al. VACCINE
- The control of CD4+CD25+Foxp3+ regulatory T cell survival
- (2008) Pushpa Pandiyan et al. Biology Direct
- CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
- (2008) B. Kavanagh et al. BLOOD
- CD8+ T-Cell Responses against Hemoglobin- Prevent Solid Tumor Growth
- (2008) H. Komita et al. CANCER RESEARCH
- Neem leaf glycoprotein directs T-bet–associated type 1 immune commitment
- (2008) Anamika Bose et al. HUMAN IMMUNOLOGY
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
- (2008) Pingyan Cheng et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neem Leaf Glycoprotein Induces Perforin-mediated Tumor Cell Killing by T and NK Cells Through Differential Regulation of IFNγ Signaling
- (2008) Anamika Bose et al. JOURNAL OF IMMUNOTHERAPY
- Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation
- (2008) Koustav Sarkar et al. VACCINE
- Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance
- (2007) Krishnendu Chakraborty et al. INTERNATIONAL IMMUNOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More